Etiometry Joins Forces with SRHO to Enable AI-based Decision Support in High-acuity Hospital Units across the U.S.

Partnership aims to improve outcomes and drive cost efficiencies within critical care units of SRHO – The National Organization member hospitals through the use of Etiometry’s clinically-proven decision support platform

BOSTON–(BUSINESS WIRE)–Etiometry, a leader in clinical intelligence technology for critical care entered a strategic partnership with SRHO – The National Association. The partnership is set to empower SRHO’s esteemed members with revolutionary tools to drive quality improvement initiatives that improve outcomes of critically ill patients and deliver cost efficiencies for critical care units across the hospital.




Etiometry’s clinical decision support platform maximizes high-acuity care teams’ situational awareness by visualizing all patient data that are continuously streamed from monitors, devices, and the EHR to show trends over time on one screen – from anywhere, so clinicians can access from the bedside, a workstation on wheels, remotely via VPN or at a central command center. The platform also helps clinicians anticipate patient deterioration with FDA-cleared risk algorithms, which flag risk of inadequate oxygen delivery or ventilation of carbon dioxide and other conditions, for the care team to determine if early intervention is needed.

Etiometry’s Clinical Pathway Automation streamlines clinical workflows by embedding hospital-specific best practices to standardize the escalation and de-escalation of care in the ICU. Automatically informing clinicians when patients have met criteria for clinical workflows directly impacts outcomes while helping newer nurses manage complex patients. Hospitals can also easily measure quality initiatives and refine workflows with the Etiometry QI App and automated reports.

“Hospitals should consider taking advantage of SRHO’s first clinical partnership targeting the ICU if they’re seeking a turnkey solution to achieve that elusive balance between standardized and individualized care. The published data on Etiometry are compelling – both clinically and operationally,” said Mark Tribbett, Chief Executive Officer at SRHO, a consortium of Strategic Regional Healthcare Organizations aimed at supporting each member’s unique challenges. “At the end of the day, the platform’s capabilities meet the real needs of our representative hospitals, including the ability to decrease length of stay and readmissions, as well as minimize time on vasoactive medications and mechanical ventilation.”

“We are excited to partner with SRHO and get to know its member health systems,” said Shane Cooke, CEO of Etiometry. “Etiometry was created by and for clinicians, so we deeply appreciate the challenges providers face and we’re always excited to help them achieve material quality improvements. Our team developed an easy solution to gauge success of a team’s quality improvement initiatives and demonstrate true value in terms of outcomes. Ancillary benefits address any strains on hospital budgets with the significant cost savings and potential additional revenue associated with our platform use.”

Interested Hospitals and regional SRHOs should contact SRHO – The National Association or Etiometry at info@etiometry.com for more information about accessing the benefits of the partnership.

About Etiometry

Founded in 2010, Etiometry is the leader in clinical decision-support software designed to help clinicians in the intensive care setting make data-based decisions regarding their patients’ care and treatment. The company’s technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patients’ conditions to avoid complications and speed recovery. Etiometry has nine FDA clearances and four Health Canada approvals and CE markings. With roots in pediatric ICUs, Etiometry is utilized by some of the world’s top academic medical centers as well as leading children’s hospitals ranked by US News and World Report and Newsweek. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering the cost of care through the more effective use of data.

The Etiometry Platform is the only critical care software solution that reveals deep insights into patient physiology, helping critical care teams deliver standardized and individualized care – and provides the ability to automate care escalation and de-escalation decisions. It is designed to facilitate the use of all available data to support the anticipation and management of the dynamic condition of patients requiring intensive care. To learn more, visit www.etiometry.com.

About SRHO – The National Association

SRHO (www.SRHO.org), representing over 375 Hospitals and Health Care Systems, was created to assist regional SRHOs in the advancement of their common interests, to develop regional or national markets to create the scale required to achieve next-level strategic cost reductions and to design the fundamental building blocks to manage risk and improve quality of care all while sustaining their organizational autonomy.

Contacts

Gina O’Connell

Etiometry Marketing

651-983-8391

goconnell@etiometry.com

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

1 day ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago